Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
298K
-
Shares change
-
+57.3K
-
Total reported value, excl. options
-
$1.13M
-
Value change
-
+$254K
-
Put/Call ratio
-
0.54
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$3.79
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q2 2020
15 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q2 2020.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 298K shares
of 129M outstanding shares and own 0.23% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (121K shares), GEODE CAPITAL MANAGEMENT, LLC (89.9K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (71.4K shares), Federation des caisses Desjardins du Quebec (13.6K shares), NORTHERN TRUST CORP (10.7K shares), Tower Research Capital LLC (TRC) (1.68K shares), UBS Group AG (1.59K shares), GROUP ONE TRADING, L.P. (1.2K shares), BlackRock Inc. (615 shares), and VICTORY CAPITAL MANAGEMENT INC (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.